Skip to main content
S&P 5007,628.11-1.20%DOW52,205.98-0.26%NASDAQ25,593.82-2.26%BTC$77,064.00-3.57%ETH$2,222.33-4.04%GOLD$3,940.10-2.26%OIL$103.80+1.76%
Smart Investors Daily
SID Premium
IR

NASDAQ · IRMD

IRadimed Corporation

Healthcare · Medical - Devices

$85.74

Up+$1.81 (+2.16%)

Updated Oct 30, 2026, 12:57 PM

SID Score

3.2/10

Composite research score

Smart Money

—

Institutional and insider signal

Market cap
1.24B
P/E ratio
59.92
Dividend yield
1.38%
52-week range
$75.75 – $107.90
Volume
92.62K
Avg. volume
68.21K

Price performance · IRMD

IRMD price history

1M range · 21 trading sessions · Daily adjusted prices

Prices through Oct 29, 2026

IRMD closed at $85.74 after 21 trading sessions, up 0.52% for the selected period.

Last close
$85.74
Period change
+0.52%
Period low
$83.93
Period high
$89.83
Daily close
View OHLC price history
IRMD OHLC price history, latest 40 sessions
DateOpenHighLowCloseVolume
Oct 29, 2026$84.80$86.93$84.80$85.7492.62K
Oct 28, 2026$83.81$85.03$83.55$83.93161.63K
Oct 27, 2026$84.45$84.56$83.54$83.95127.14K
Oct 26, 2026$85.82$86.07$84.24$84.63182.48K
Oct 23, 2026$87.44$87.90$85.46$85.82106.82K
Oct 22, 2026$88.15$89.485$87.10$87.6493.09K
Oct 21, 2026$87.85$88.89$87.21$87.8165.88K
Oct 20, 2026$88.30$89.425$87.69$88.2483K
Oct 19, 2026$88.48$88.78$86.98$87.6579.23K
Oct 16, 2026$89.53$90.43$88.095$88.2781.82K
Oct 15, 2026$90.33$91.05$89.125$89.3780.63K
Oct 14, 2026$89.61$90.43$89.39$89.8373.5K
Oct 13, 2026$89.93$90.46$88.05$89.6594.74K
Oct 12, 2026$87.82$89.67$86.86$89.47111.5K
Oct 9, 2026$85.56$87.48$85.56$87.4568.87K
Oct 8, 2026$85.59$86.55$84.58$85.8891.61K
Oct 7, 2026$84.55$86.77$83.84$85.47197.89K
Oct 6, 2026$87.08$87.08$84.34$84.82118.61K
Oct 5, 2026$85.28$86.61$85.00$86.4776.96K
Oct 2, 2026$86.14$86.27$84.525$85.40119.45K
Oct 1, 2026$86.20$87.415$84.74$85.30174.67K

Latest IRMD news

The latest Smart Investors Daily articles mentioning IRMD.

Stock researchCompany · Overview

IRMD research

Overview

Company profile and research snapshot.

Company profile

iRadimed Corp develops, manufactures, markets and distributes a Magnetic Resonance Imaging (MRI) compatible intravenous (IV) infusion pump system, and MRI compatible patient vital signs monitoring system, and accessories and services relating to them. The company provides a non-magnetic IV infusion pump system which is designed to be safe for use during MRI procedures. The MRI products of the company are sold to hospitals and acute care facilities in the United States and internationally. It generates majority revenue from United States.

Visit company website

Analyst outlook

Consensus and target data currently published for this company.

Consensus
—
Average target
$99.00
Implied upside
—
Analysts
—
IRMD recent ratings
DateFirmRatingTarget
Sep 22, 2026NeedhamHold—
Feb 14, 2025Roth MKMBuy—
Aug 2, 2024Roth MKMBuy—
Apr 22, 2024Roth MKMBuy—
Aug 2, 2021Roth CapitalBuy—
Open full forecast

News briefing

No generated briefing is available yet.

Yahoo · Oct 23, 2026

IRADIMED CORPORATION to Hold Third Quarter 2026 Financial Results Conference Call on October 30, 2026

ORLANDO, Fla., Oct. 23, 2026 (GLOBE NEWSWIRE) -- IRADIMED CORPORATION (NASDAQ: IRMD) announced today that the Company will release its 2026 third quarter financial results before the market opens on Friday, October 30, 2026. Iradimed management will host a conference call the same day beginning at 11:00 a.m. Eastern Time to discuss those results and to answer questions. Individuals interested in participating in the conference call may do so by registering here, https://register-conf.media-serve

Yahoo · Sep 23, 2026

IRADIMED CORPORATION To Participate in the 5th Annual ROTH Healthcare Opportunities Conference

ORLANDO, Fla., Sept. 23, 2026 (GLOBE NEWSWIRE) -- IRADIMED CORPORATION (“Iradimed”) (NASDAQ: IRMD), a leading provider of innovative magnetic resonance imaging (MRI) compatible medical devices, announced today that it will participate in the 5th Annual ROTH Healthcare Opportunities Conference. Iradimed’s CFO, Jack Glenn, will host one-on-one meetings between company management and investors at the 5th Annual ROTH Healthcare Opportunities Conference at the Metropolitan Club in New York on Septemb

AI research layers

Interpretive context generated from the platform’s current data sources.

No results

AI research layers have not been published yet.

Featured By